Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2016 group results

Feb 14 (Reuters)-  
          Cosmo Bio Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Dec 31, 2016    Dec 31, 2015   Dec 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           7.43            7.36           7.50          3.90     
               (+1.0 pct)      (+1.7 pct)     (+1.0 pct)    (-2.1 pct)  
  Operating      514 mln         200 mln        115 mln      115 mln    
              (+156.3 pct)     (+23.7 pct)    (-77.6 pct)  (-68.2 pct)  
  Recurring      483 mln         373 mln        180 mln      165 mln    
               (+29.5 pct)     (+30.9 pct)    (-62.8 pct)  (-55.1 pct)  
  Net 
  Net            254 mln         230 mln        105 mln      105 mln    
               (+10.4 pct)     (+14.3 pct)    (-58.7 pct)  (-59.2 pct)  
  EPS           42.93 yen       38.89 yen      17.71 yen    17.71 yen   
  Ann Div       18.00 yen       16.00 yen      14.00 yen                
  -Q2 Div       6.00 yen        6.00 yen       6.00 yen                 
  -Q4 Div       12.00 yen       10.00 yen      8.00 yen                 
   
  NOTE - Cosmo Bio Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Cosmo Bio

See all news